好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Press Release

EMBARGOED FOR RELEASE UNTIL 4 PM ET, December 01, 2021

Who Develops Mild Cognitive Impairment? What Predicts Who Then Develops Dementia?

Nearly Half of Those with Mild Cognitive Impairment No Longer Met Criteria at Follow-up

MINNEAPOLIS - A new study looks at factors that may help predict who will develop thinking and memory problems called mild cognitive impairment (MCI), and who will develop dementia among those with MCI. The study is published in the December 1, 2021, online issue of , the medical journal of the 好色先生. Of those who were diagnosed with mild cognitive impairment during the study, researchers found that nearly half were later classified as cognitively normal at their follow-up visit an average of 2.4 years later. 鈥淭hese results will help us to better understand who is at high risk for dementia so we can identify people for prevention strategies or intervention methods,鈥 said study author Jennifer J. Manly, PhD, of Columbia University in New York, NY. 鈥淓specially where risk factors can be modified, these results could be important for public health initiatives. The results highlight that MCI is a classification associated with increased risk for progression, but not everyone goes on to develop dementia.鈥 The study found that having more years of education, taking part in more leisure activities such as reading, visiting a friend or going for a walk as well as having a higher income were predictors of a lower risk of developing MCI. Having a higher number of other medical conditions and having a gene that increases the risk of dementia were predictors of a higher risk of developing MCI. Among the people with MCI, factors that increased the risk of developing dementia were use of antidepressants, having symptoms of depression, having the gene that increases risk and having MCI that affects several aspects of thinking skills, such as memory, language and spatial skills. The study involved 2,903 people with no thinking or memory problems. Of the group, 31% identified as Black or African American, 43% as Hispanic or Latino, and 27% as White. Also, 40% were evaluated in Spanish. Participants had an average age of 76 and were followed for an average of six years. During that time, 480 people were diagnosed with mild cognitive impairment. To be diagnosed with MCI, people had to meet criteria including: they themselves report that they are having problems with memory or thinking skills; a test shows that they have cognitive impairment; and they are still able to maintain their daily activities, with problems with fewer than three activities such as shopping or handling medications. Of the people diagnosed with MCI, at a follow-up visit an average of two years later, 13% had developed dementia, 30% still met the criteria for MCI and 10% declined in their functioning but did not meet the criteria for MCI or dementia. Another 48% no longer met the criteria for MCI. Of those, people may have had one or two of the three criteria, but not all three. For example, they may have reported memory problems that did not show up on tests or vice versa. In looking at who was likely to develop MCI, people with more years of education were about 5% less likely to develop MCI. Those with no MCI had an average of 11.5 years of education, compared to 9.9 years for those who developed MCI and 7 years for those who developed dementia. People who took part in more leisure activities were about 5% less likely to develop MCI. Those with no MCI took part in an average of 7.5 of 13 leisure activities, compared to 7.4 for those who developed MCI and 5.8 for those who developed dementia. In looking at who with MCI was likely to develop dementia, people who used antidepressant were more likely to develop dementia, with 18% of those who developed dementia using antidepressants, compared to 7% of those who continued with an MCI diagnosis and 6% of those who no longer met the criteria for MCI. Similarly, 21% of those who developed dementia had symptoms of depression, compared to 12% of those who continued with an MCI diagnosis and 10% of those who no longer met the MCI criteria. Limitations of the study were that the number of people who developed MCI and were available for follow-up was relatively small and the follow-up time was relatively short. 鈥淔uture research should investigate the course of MCI across a longer period of time to further dissect which factors can best help us understand the development of dementia,鈥 Manly said. 鈥淚t should also be noted that these results do not mean that these risk factors cause dementia or will always lead to dementia; they just show an association.鈥 The study was supported by the Washington Heights-Inwood Columbia Aging Project, National Institute on Aging, National Center for Advancing Translational Sciences and National Institutes of Health. Learn more about mild cognitive impairment at , home of the 好色先生鈥檚 free patient and caregiver magazine focused on the intersection of neurologic disease and brain health. Follow Brain & Life on , and . When posting to social media channels about this research, we encourage you to use the hashtags #Neurology and #AANscience.

Brain & Life logo

GET A DOSE OF BRAIN HEALTH

Dive into a wealth of information by visiting Brain & Life庐, where you can explore the freshest updates, tips, and neurologist expert perspectives on brain disease and preventive brain health.


The 好色先生 is the leading voice in brain health. As the world鈥檚 largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN鈥檚 mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at or find us on , , , and .

For More Information*

Email media@aan.com

*While content of the 好色先生 (AAN) press releases is developed by the AAN along with research authors and Neurology® editors, we are unable to provide medical advice to individuals. Please contact your health care provider for questions specific to your individual health history or care. For more resources, visit the AAN's patient and caregiver magazine website, .